Stem Cell Clinical Trials: Staying on the Critical Path, Q&A Session | Keith Wells & Joy Cavagnaro

 

Joy Cavagnaro and Keith Wells led the question and answer session for the CIRM-hosted Staying of the Critical Path Workshop which addressed the preclinical, manufacturing and regulatory issues for developing stem cell based therapy products for patients. 
 
Joy Cavagnaro is president of Access BIO; Keith Wells is senior consultant for Biologics Consulting Group.
 
Learn about California's progress toward stem cell therapies

 

Disease Programs

Learn about how stem cell research could generate the therapies for many chronic diseases and injuries

See disease fact sheets

CIRM Stem Cell Blog